The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Effect of Rituximab on EBV - Prof Edwards?

Discussion in 'Rituximab: News and Research' started by Anne, Jul 15, 2015.

  1. Anne

    Anne Senior Member

    Messages:
    295
    Likes:
    723
    @Jonathan Edwards

    Prof Edwards,

    Apologies if this has already been discussed, but I'm wondering:

    Since Epstein-Barr virus resides in B-cells (if I understand this correctly), does Rituximab extinguish an active or re-activating EBV?

    I know this mechanism is not likely to be the cause of the response in ME patients given Rituximab, since the delayed response indicates an autoimmune mechanism, but all the same: if a patient with an active or re-activated EBV infection was given Rituximab, would they be cleared of the EBV?

    Many thanks in advance! Your participation in the discussions here is much appreciated.
     
  2. Jonathan Edwards

    Jonathan Edwards "Gibberish"

    Messages:
    5,211
    Likes:
    31,646
    Rituximab has been used to get rid of clinically active EBV infection in the context of lymphoma and it seems to clear the presence of virus, although it probably does not get rid of all viral DNA. Rituximab almost certainly does not get rid of all B cells. As far as I am aware EBV reactivation only occurs in the context of some pretty severe interference with the immune system like lymphoma or bone marrow transplant preparation.
     
  3. Anne

    Anne Senior Member

    Messages:
    295
    Likes:
    723
    Kati likes this.

See more popular forum discussions.

Share This Page